HRID2098713

反应详情

EQUATION

反应方程式

HRID 2098713 的结构方程式

PROCEDURE

实验过程

Tert-butyl 2-chloro-4-morpholinothieno[3,2-d]pyrimidin-6-ylcarbamate (50 mg) was coupled to 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole 7 via General Procedure A. The product was purified by reverse phase HPLC to yield 8.8 mg of 225. MS (Q1) 353 (M)+

WORKUP

后处理

  1. customThe product was purified by reverse phase HPLC